tirzepatide vs wegovy dosage and Semaglutide key differences, weight loss results (2026) Wegovy Tablets vs Mounjaro (Tirzepatide):
Description
P = 0.004) (Table 3 and Fig
In my clinical experience, tirzepatide may cause slightly less nausea or constipation, yet may have a slightly higher tendency to cause diarrhea
One trial showed participants taking 7.2mg weekly losing on average 18.7%, with many reaching 20-25% weight loss thresholds
A single molecule called Mounjaro stimulates insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
However, the safest treatment depends on the patient, not the trend
